{"entity":{"id":"nct07544056","kind":"trial","name":"A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer","aka":[],"tldr":"A phase 2/3 trial testing BEBT-209 in triple-negative breast cancer, now recruiting.","summary":"A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer is a phase 2/3 interventional study registered as NCT07544056, led by BeBetter Med with Hunan Cancer Hospital and Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, and recruiting on the registry. Official title: A Randomised, Controlled, Open-label, Multi-centre, Phase IIb/III Clinical Study to Evaluate BEBT-209 Plus Carboplatin and Gemcitabine Versus Carboplatin Plus Gemcitabine in Locally Advanced or Metastatic Triple-Negative Breast Cancer. Planned enrolment is 446 participants (estimated). The study started in 2026-06-04 and primary completion is expected in 2030-06. No results have been posted on ClinicalTrials.gov.","status":"recruiting","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov NCT07544056","url":"https://clinicaltrials.gov/study/NCT07544056"}],"tags":["ctgov-ingest"],"related":[],"cancers":["tnbc","tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":["bebt-209"],"companies":["bebetter-med"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07544056","phase":"2/3","setting":"A Randomized, Controlled, Open-label, Multi-center, Phase IIb/III Clinical Study to Evaluate BEBT-209 Plus Carboplatin and Gemcitabine Versus Carboplatin Plus Gemcitabine in Locally Advanced or Metastatic Triple-Negative Breast Cancer","sponsor":"BeBetter Med","started":"2026-06-04","startedType":"actual","enrolled":446,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07544056/","neighbours":{"cancer":[{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"drug":[{"id":"bebt-209","kind":"drug","name":"BEBT-209","route":"/drugs/bebt-209/"}],"company":[{"id":"bebetter-med","kind":"company","name":"BeBetter Med","route":"/companies/bebetter-med/"}]}}